Siglecs as immune cell checkpoints in disease
S Duan, JC Paulson - Annual review of immunology, 2020 - annualreviews.org
Sialic acid–binding immunoglobulin-type lectins (Siglecs) are expressed on the majority of
white blood cells of the immune system and play critical roles in immune cell signaling …
white blood cells of the immune system and play critical roles in immune cell signaling …
Glycomimetics for the inhibition and modulation of lectins
Carbohydrates are essential mediators of many processes in health and disease. They
regulate self-/non-self-discrimination, are key elements of cellular communication, cancer …
regulate self-/non-self-discrimination, are key elements of cellular communication, cancer …
The AutoDock suite at 30
The AutoDock suite provides a comprehensive toolset for computational ligand docking and
drug design and development. The suite builds on 30 years of methods development …
drug design and development. The suite builds on 30 years of methods development …
Multivalent glycosystems for human lectins
M Martínez-Bailén, J Rojo… - Chemical Society …, 2023 - pubs.rsc.org
Human lectins are involved in a wide variety of biological processes, both physiological and
pathological, which have attracted the interest of the scientific community working in the …
pathological, which have attracted the interest of the scientific community working in the …
Siglec ligands
A Gonzalez-Gil, RL Schnaar - Cells, 2021 - mdpi.com
A dense and diverse array of glycans on glycoproteins and glycolipids decorate all cell
surfaces. In vertebrates, many of these carry sialic acid, in a variety of linkages and glycan …
surfaces. In vertebrates, many of these carry sialic acid, in a variety of linkages and glycan …
Glycotherapy: new advances inspire a reemergence of glycans in medicine
JE Hudak, CR Bertozzi - Chemistry & biology, 2014 - cell.com
The beginning of the 20 th century marked the dawn of modern medicine with glycan-based
therapies at the forefront. However, glycans quickly became overshadowed as DNA-and …
therapies at the forefront. However, glycans quickly became overshadowed as DNA-and …
Siglec and anti-Siglec therapies
G Murugesan, B Weigle, PR Crocker - Current opinion in chemical biology, 2021 - Elsevier
Siglecs (sialic acid–binding immunoglobulin-like lectins) are a family of receptors that bind
sialic acids in specific linkages on glycoproteins and glycolipids. Siglecs play roles in …
sialic acids in specific linkages on glycoproteins and glycolipids. Siglecs play roles in …
Sialic acid mimetics to target the sialic acid–Siglec axis
Sialic acid sugars are vital regulators of the immune system through binding to
immunosuppressive sialic acid-binding immunoglobulin-like lectin (Siglec) receptors on …
immunosuppressive sialic acid-binding immunoglobulin-like lectin (Siglec) receptors on …
Carbohydrate-based nanocarriers and their application to target macrophages and deliver antimicrobial agents
Many deadly infections are produced by microorganisms capable of sustained survival in
macrophages. This reduces exposure to chemadrotherapy, prevents immune detection, and …
macrophages. This reduces exposure to chemadrotherapy, prevents immune detection, and …
Siglec-6 mediates the uptake of extracellular vesicles through a noncanonical glycolipid binding pocket
Immunomodulatory Siglecs are controlled by their glycoprotein and glycolipid ligands.
Siglec-glycolipid interactions are often studied outside the context of a lipid bilayer, missing …
Siglec-glycolipid interactions are often studied outside the context of a lipid bilayer, missing …